Cardiovascular risk factors in the elderly

Coronary Artery Disease

Volumn 8, Issue 8-9, 1997, Pages 565-575

  Kannel, William B ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; HOMOCYSTEINE;

AGED; CARDIOVASCULAR RISK; DYSLIPIDEMIA; EXERCISE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SMOKING; WEIGHT REDUCTION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LIPIDS; MALE; MULTIVARIATE ANALYSIS; OBESITY; RECURRENCE; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES;

EID: 0030664190     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Chartbook on Cardiovascular, Lung and Blood Diseases: Morbidity and Mortality. NIH NHLBI, 1996. US Department of Health and Human Services. PHS.
2. Groves EJ: Detailed Diagnoses and Procedures. National Hospital Discharge Summary. 1991. Washington DC. NCHS Public No (PHS) 94-1517 (Vital and Health Statistics: Series 13, No. 15).
3. National Center for Health Statistics: National Hospital Discharge Survey. Vital and Health Statistics: Series 13 (issues from 1970 to 1991).
4. Kannel WB, D'Agostino RB. The importance of cardiovascular risk factors in the elderly. Am J Geriatric Cardiol 1995, March/April: 10-23.
5. Kannel WB, D'Agostino RB, Belanger AJ: Concept of bridging the gap from youth to adulthood. Am J Med Sci 1995, 320:515-521.
6. Kannel WB, D'Agostino RB, Cobb JL: The impact of weight on cardiovascular disease. Am J Clin Nutr 1996, 63 (suppl):419S.
7. Walton C, Lees B, Crook D, Worthington M, Godsland IF, Stevenson JC: Body fat distribution rather than overall obesity, influences serum lipids and lipoproteins in healthy men independently of age. Am Med J Med 1995, 99:495.
8. Nakamura T, Tokunaga K, Shimomura I, et al.: Contribution of visceral fat to the development of coronary disease in non-obese men. Atherosclerosis 1994, 107:239.
9. Bjorntorp P: Portal adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990, 10:943.
10. Hartz AJ, Rupley DC, Rimm AA: The association of girth measurement with disease in 32,856 women. Am J Epidemiol 1984, 119:71.
11. Kannel WB, Cupples LA, Ramaswami R, Stokes J III. Kreger B, Higgins M: Regional obesity and risk of cardiovascular disease: the Framingham Offspring Study. J Clin Epidemiol 1991, 44:183.
12. Bouchard C: Is weight fluctuation a risk factor? N Engl J Med 1991, 324:1887.
13. Lissner L, Odell PM, D'Agostino RB, et al.: Variability in body weight and health outcomes in the Framingham population. N Engl J Med 1991, 324:1839.
14. Hamm P, Shekelle RB, Stamler J: Large fluctuations in body weight during young adulthood and 25 year risk of coronary death in men. Am J Epidemiol 1989, 129:312.
15. Andres R, Muller DS, Sorkin JD: Long term effects of change in body weight on all cause mortality. A review. Ann Intern Med 1993, 119:737.
16. Andres R, Elihi D, Tobin JD, Muller DC, Brant L: Impact of age on weight goals. Ann Intern Med 1985, 103:1030.
17. Garrison RJ, Kannel WB: A new approach for estimating body weights. Int J Obesity 1993, 17:417.
18. Bulpitt CJ, Fletcher AE: Prognostic significance of blood pressure in the very old: implications in the treatment decision. Drugs Aging 1994, 5:184.
19. Insua JT, Sacks HS, Lau T-S, et al.: Drug treatment of hypertension in the elderly. Ann Intern Med 1994, 121:355-362.
20. Wilson PWF, Kannel WB: Hypercholesterolemia and coronary risk in the elderly: The Framingham Study. Am J Geriat Cardiol 1993, March/April:52
21. 7Kannel WB: Hypertension. In Vascular Disease in the Elderly. Edited by Aronow WS, Stemmer EA, Wilson SE, Armonk, NY: Futura Publishing Co. Inc., 1997.
22. Langer RD, Graniats TG, Barrett-Conner E: Factors associated with paradoxical survival at higher blood pressures in the very old. Am J Epidemiol 1991, 134:29-38.
23. Cruickshank JM, Thorp JM, Zacharias FJ: Benefits and potential harm of lowering blood pressure. Lancet 1987, 1:581-584.
24. Kannel WB: Epidemiology of essential hypertension: The Framingham Experience. Proc R Coll Physicians Edin 1991, 21:273-287.
25. Kannel WB: Lipids, nutrition and CVD in the elderly. In Dietary Fat Requirements in Health & Development. Edited by Beare Rogers J. Champaign. Illinois: American Oil Chemists Society; 1988:191-200.
26. Kannel WB, Wilson PWF: Update on hyperlipidemia in the elderly: is this a risk factor for heart disease? Am J Geriatr Card 1996, 5: 9-14.
27. National Cholesterol Education Program: Second Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994, 89:1333-1445.
28. La Rosa JC: Should high lipid values in very old patients be lowered? Drugs Aging 1995, 6:85-90.
29. Kannel WB: Epidemiology in CVD in the elderly: an assessment of risk factors. In Geriatric Cardiology. Edited by Brest DT, Lowenthal AN. Philadelphia: FA Davis Co.; 1992:13.
30. D'Agostino RB, Kannel WB, Stepanians MN, et al.: Efficiency and tolerability of lovastatin in elderly hypercholesterolemic patients. Clin Therap 1992, 14:68-76.
31. Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Study (4S). Lancet 1994, 344: 1383-1389.
32. Sacks FM, Pleffer MA, Moye LA, Rouleau JL, Cole TG, Brown L, et al. for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996, 335:1001-1009.
33. Rossouw J: Lipid lowering interventions in angiographic trials. Am J Cardiol 1995, 76:86c-92c.
34. Byington RP, Jukema JW, Salonen JT, et al.: Reduction in cardiovascular events during pravastatin therapy: pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation 1995, 92:2419-2425.
35. American College of Physicians: Guidelines for using serum cholesterol, high-density lipoprotein cholesterol and triglyceride as screening tests for preventing coronary heart disease in adults. Ann Intern Med 1996, 124:515-517.
36. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor. A meta-analysis and review of the literature. Ann Intern Med 1993, 118:956-963.
37. Kannel WB, Anderson KM, Wilson PWF: White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992, 267:1253-1256.
38. Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham Study. JAMA 1979, 241:2305-2308.
39. Kannel WB: Natural history of CV risk. In Atlas of Heart Diseases. Hypertension: Mechanisms & Therapy. Edited by Braunwald E, Hollenberg NK. Philadelphia: Current Medicine, 1994:5.2-5.22.
40. Wilson PWF, Cupples LA, Kannel WB: Is hyperglycemia associated with cardiovascular disease? The Framingham Study. Am Heart J 1991, 121:586-590.
41. Reaven GM, Chen YD: Insulin resistance, its consequences and coronary heart disease. Must we choose one culprit? [editorial comment]. Circulation 1996, 93:1780-1783.
42. Kannel WB, Dannenberg AL, Levy D: Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol 1987, 60:193-1.
43. Kannel WB: Rationale for treatment of hypertension in the elderly. Am J Geriat Cardiol 1994, May/June:33-45.
44. Kannel WB, Wilson PWF: Homocysteine, folate and vascular disease. J Myocard Isch 1996, 8:60.
45. SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992, 327:685-691.
46. Kannel WB: Need and prospects for prevention of cardiac failure. Eur J Clin Pharmacol 1996, 49:S3-S6.
47. Kannel WB, Brand FN: Cardiovascular risk factors in the elderly. In Principles of Geriatric Medicine. Edited by Anders R, Bierman EL, Hazzard WR, New York: McGraw Hill; 1985:104-119.
48. Wolf PA, D'Agostino RB, Bellanger AJ, Kannel WB: Probability of stroke: a risk profile from the Framingham Study. Stroke 1991, 22:312-318.
49. Anderson KM, Wilson PWF, Odell PM, Kannel WB: An updated coronary risk profile. A statement for physicians. Circulation 1991, 83:356-362.